Skip to content
2000
image of 5-Alpha Reductase Deficiency - An Uncommon Disorder of Sexual Development: A Case Study of Four Turkish Patients within a Family

Abstract

Introduction

5-alpha reductase deficiency is an inherited autosomal recessive disorder that can present with severe masculinization defects and ambiguous genitalia. Up to more than 100 mutations have been reported, but phenotype and genotype associations have not been directly evidenced. Testosterone-to-dihydrotestosterone (T/DHT) ratio is a clinically diagnostic test, and the cut-off value is expected to be higher than 10.

Case Presentation

This brief report of 4 patients with deficiency in the same family has focused on the clinical and biochemical features of patients with the same mutation. A 14-year-old patient with c193G>C, p. Ala65Pro in gene had primary amenorrhea and bilateral palpable mass in the inguinal canal. After a detailed physical examination and karyotype analysis, the patient was diagnosed with deficiency with a 46, XY karyotype. In addition, the other affected siblings had the same clinical phenotype and low masculinization score. T/DHT ratio of all siblings was 14.5, 2.1, 3.7, and 19.2, respectively. Although all of them had the same genetic mutations with a homozygous pattern (c193G>C, p. Ala65Pro), a different T/DHT ratio was observed in our study.

Conclusion

The definitive diagnosis of deficiency requires molecular testing, but it is currently not available in some centers. Therefore, clinical phenotype and biochemical screening, especially the T/DHT ratio, should be used for evaluating this hereditary syndrome. However, we must consider that the diagnostic sensitivity of the stimulated T/DHT ratio can be affected by various factors, such as age, ethnicity, or the presence of residual enzyme activity.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cgt/10.2174/0115665232415806250922094852
2025-10-14
2025-12-14

  • From This Site

    /content/journals/cgt/10.2174/0115665232415806250922094852
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Baetens D. Mladenov W. Delle Chiaie B. Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development. Orphanet J. Rare Dis. 2014 9 1 209 10.1186/s13023‑014‑0209‑2 25497574
    [Google Scholar]
  2. Chan A.O.K. But B.W.M. Lee C.Y. Diagnosis of 5α-reductase 2 deficiency: Is measurement of dihydrotestosterone essential? Clin. Chem. 2013 59 5 798 806 10.1373/clinchem.2012.196501 23513070
    [Google Scholar]
  3. Bertelloni S. Baldinotti F. Russo G. 5alpha-reductase-2 defciency: Clinical fndings, endocrine pitfalls, and genetic features in a large Italian cohort. Sex Dev. 2016 10 1 28 36 10.1159/000445090 27070133
    [Google Scholar]
  4. Bertelloni S. Scaramuzzo R.T. Parrini D. Baldinotti F. Tumini S. Ghirri P. Early diagnosis of 5alpha-reductase deficiency in newborns. Sex Dev. 2007 1 3 147 151 10.1159/000102103 18391525
    [Google Scholar]
  5. Ko J.M. Cheon C.K. Kim G.H. Kim S.H. Kim K.S. Yoo H.W. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency. Horm. Res. Paediatr. 2010 73 1 41 48 10.1159/000271915 20190539
    [Google Scholar]
  6. Quin K. Genetic defect of androgen resistance. In: Weiss RE, Refetoff S, Eds.Genetic Diagnosis of Endocrine Disorders. Weiss R.E. Refetoff S. London Elsevier 2010 245 249 10.1016/B978‑0‑12‑374430‑2.00022‑5
    [Google Scholar]
  7. Avendaño A. Paradisi I. Cammarata-Scalisi F. Callea M. 5-α-Reductase type 2 deficiency: Is there a genotype-phenotype correlation? A review. Hormones 2018 17 2 197 204 10.1007/s42000‑018‑0013‑9 29858846
    [Google Scholar]
  8. Mazen I. Hafez M. Mamdouh M. Sultan C. Lumbroso S. A novel mutation of the 5alpha-reductase type 2 gene in two unrelated Egyptian children with ambiguous genitalia. J. Pediatr. Endocrinol. Metab. 2003 16 2 219 224 10.1515/JPEM.2003.16.2.219 12713261
    [Google Scholar]
  9. Shabir I. Khurana M.L. Joseph A.A. Eunice M. Mehta M. Ammini A.C. Phenotype, genotype and gender identity in a large cohort of patients from India with 5 α ‐reductase 2 deficiency. Andrology 2015 3 6 1132 1139 10.1111/andr.12108 26453174
    [Google Scholar]
  10. Domenice S. Sircili M. Inacio M. Mendonca B. Costa E. DSD due to 5α-reductase 2 deficiency - From diagnosis to long term outcome. Semin. Reprod. Med. 2012 30 5 427 431 10.1055/s‑0032‑1324727 23044880
    [Google Scholar]
  11. Maimoun L. Philibert P. Cammas B. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: An extensive international experience of 55 patients. J. Clin. Endocrinol. Metab. 2011 96 2 296 307 10.1210/jc.2010‑1024 21147889
    [Google Scholar]
  12. Walter K.N. Kienzle F.B. Frankenschmidt A. Difficulties in diagnosis and treatment of 5α-reductase type 2 deficiency in a newborn with 46,XY DSD. Horm. Res. Paediatr. 2010 74 1 67 71 10.1159/000313372 20395661
    [Google Scholar]
  13. Mendonca B.B. Batista R.L. Domenice S. Steroid 5α-reductase 2 deficiency. J. Steroid Biochem. Mol. Biol. 2016 163 206 211 10.1016/j.jsbmb.2016.05.020 27224879
    [Google Scholar]
  14. Pang S. Levine L.S. Chow D. Sagiani F. Saenger P. New M. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J. Clin. Endocrinol. Metab. 1979 48 5 821 826 10.1210/jcem‑48‑5‑821 429527
    [Google Scholar]
  15. Ng K.L. Ahmed S.F. Hughes I.A. Pituitary-gonadal axis in male undermasculinisation. Arch. Dis. Child. 2000 82 1 54 58 10.1136/adc.82.1.54 10630914
    [Google Scholar]
  16. Bertelloni S. Dati E. Ghione S. Baroncelli G.I. Human chorionic gonadotropin test in childhood: Update. Expert Rev. Endocrinol. Metab. 2010 5 615 623
    [Google Scholar]
  17. Kamrath C. Wudy S.A. Krone N. Steroid biochemistry. Endocr. Dev. 2014 27 41 52 10.1159/000363612 25247643
    [Google Scholar]
  18. Khadgawat R. Goyal A. Kubihal S. Gupta Y. Jyotsna V.P. Dynamic testing for evaluation of adrenal and gonadal function in pediatric and adult endocrinology: An overview. Indian J. Endocrinol. Metab. 2019 23 6 593 601 10.4103/ijem.IJEM_553_19 32042694
    [Google Scholar]
  19. Di Marco C. Bulotta A.L. Varetti C. Ambiguous external genitalia due to defect of 5-α-reductase in seven Iraqi patients: Prevalence of a novel mutation. Gene 2013 526 2 490 493 10.1016/j.gene.2013.04.070 23664981
    [Google Scholar]
  20. Wisniewski A.B. Batista R.L. Costa E.M.F. Management of 46,XY differences/disorders of sex development (DSD) throughout life. Endocr. Rev. 2019 40 6 1547 1572 10.1210/er.2019‑00049 31365064
    [Google Scholar]
  21. Abacı A. Çatlı G. Kırbıyık Ö. Genotype–phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: A multicenter study from Turkey. J. Endocrinol. Invest. 2019 42 4 453 470 10.1007/s40618‑018‑0940‑y 30132287
    [Google Scholar]
/content/journals/cgt/10.2174/0115665232415806250922094852
Loading
5-Alpha Reductase Deficiency - An Uncommon Disorder of Sexual Development: A Case Study of Four Turkish Patients within a Family
Bentham Science Publishers ; https://doi.org/10.2174/0115665232415806250922094852
/content/journals/cgt/10.2174/0115665232415806250922094852
/content/journals/cgt/10.2174/0115665232415806250922094852
Loading

Data & Media loading...


  • Article Type:     Case Report
Keywords: ambiguous genitalia ; testosterone-to-DHT ratio ; SRD5A2 deficiency ; autosomal recessive disorder ; 5-alpha reductase ; masculinization defects

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test